What are the indications for Mitotane?

Mitotane (Mitotane) is a drug used to treat adrenocortical cancer. Its main indications include the following:

1.Adrenocortical Carcinoma (Adrenocortical Carcinoma, ACC): Mitotane (mitotane) is a first-line treatment drug and is often used for the long-term treatment of adrenocortical cancer. Adrenocortical carcinoma is a rare but highly malignant tumor. Patients are often invasive and metastatic, and are prone to recurrence after surgical resection. Therefore, long-term drug treatment is required to control the disease.

2.Metastatic adrenocortical cancer: Mitotane (mitotane) can also be used to treat metastatic adrenocortical cancer, especially for those patients who cannot be completely removed by surgery or have developed distant metastasis. Mitotane (mitotane) can be used to control the growth and spread of the tumor and delay the progression of the disease.

3.Adrenocortical cancer treatment before surgery: In some cases, patients may need drug treatment before surgery to reduce the size of the tumor, reduce the difficulty of surgery, and improve the success rate of surgical resection. Mitotane may be used as an option for preoperative treatment.

4.Supportive treatment that produces anti-tumor effects on tumors: Mitotane (mitotane) can also be used in the treatment of other types of tumors, such as the treatment of liver cancer, lung cancer and other tumors. Although its efficacy is not the main treatment method, it can be used as an auxiliary treatment drug in some cases.

It should be noted that Mitotane (mitotane) is currently mainly used to treat adrenocortical cancer, especially in the treatment of recurrent or metastatic adrenocortical cancer. Patients should consult a professional doctor before using mitotane, and conduct treatment according to their own condition and the doctor's guidance. In addition, Mitotane is not suitable for all patients with adrenocortical cancer. Doctors need to comprehensively consider the patient's condition, physical condition, and treatment options to determine the best treatment strategy.